Most shareholders in Johnson & Johnson (NYSE: JNJ) are content with a well-diversified, steady company that pays them a reliably growing dividend. To keep that up, the company needs to find areas of the healthcare industry in which to grow. The company began making acquisitions to jump-start growth.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting